Immunological activity of covalently linked T-cell epitopes.
about
Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphataseMechanisms of Natural Tolerance in the IntestinePeripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d IT-cell regulation of peripheral tolerance and immunity: the potential role for Notch signalling.A two-step, two-signal model for the primary activation of precursor helper T cellsPeptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model.In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B.A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigensInhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized miceT cell priming versus T cell tolerance induced by synthetic peptides.The presentation of self-peptides: tolerance and competition.Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis.Inhibition of T cell activation by MHC blockade.Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapyFusion proteins with heterologous T helper epitopes. Recombinant E. coli heat-stable enterotoxin proteins.Immunotherapy with T-cell-reactive peptides derived from allergens.Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection.Selective immunosuppression by administration of major histocompatibility complex class II-binding peptides. II. Preventive inhibition of primary and secondary in vivo antibody responses.Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
P2860
Q28507508-E265CC10-E97B-45A6-B12E-CA2F92CB0358Q29031968-ECA80FC1-3BF6-484B-815D-4D3A2B94D379Q30454050-D28C77B3-F648-497B-AB54-D104CC39830FQ33992826-9D82BDCB-CE14-4575-BDD9-877EA6E1A9B7Q34797521-69EE83F2-6792-49FE-9C24-CC6A148B5A6AQ34975904-4C8699E1-57AA-4458-873E-95B91DF1900AQ36353659-DAD2F388-7478-4884-8DDB-85555958541DQ36362238-7C620AC8-DAD0-4F4C-BE4C-2741E43D4574Q36362467-D6F03FDC-12FF-4BA4-891C-F9F9F2A844E2Q36365135-6B20A144-60BA-40EF-AC52-2615AF3ECDCBQ36676941-7046BEDC-6230-4EF2-AD50-91D92390F109Q37360604-76A9261A-9332-42E2-A995-82BCBB7FEE6FQ37611832-D40CE3F9-A794-45D0-B706-2C525098D8BBQ37804401-0FBC8F49-9499-4769-8C2F-B8AE5FB90405Q39782156-6C5AD2C5-110F-414D-BD3A-2F8CD6B74A4AQ40391192-BD58FE40-67FD-4B12-BD3F-71F7B5000A8EQ40392723-E6B7087B-FCB4-4296-98E6-36C8691DA65BQ41009448-8FFFF0B2-9E1D-4223-A807-62B674CD6C12Q41881939-E220A2E7-7D36-4474-97E2-3A9C18FE50EBQ41940214-37BBF204-C62A-44F5-B21C-FC203034555B
P2860
Immunological activity of covalently linked T-cell epitopes.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Immunological activity of covalently linked T-cell epitopes.
@en
Immunological activity of covalently linked T-cell epitopes.
@nl
type
label
Immunological activity of covalently linked T-cell epitopes.
@en
Immunological activity of covalently linked T-cell epitopes.
@nl
prefLabel
Immunological activity of covalently linked T-cell epitopes.
@en
Immunological activity of covalently linked T-cell epitopes.
@nl
P2093
P356
P1433
P1476
Immunological activity of covalently linked T-cell epitopes.
@en
P2093
P2888
P304
P356
10.1038/343381A0
P407
P577
1990-01-01T00:00:00Z
P6179
1033802710